within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G04B_Urologicals.G04BX16_Tiopronin;

model Tiopronin
  extends Pharmacolibrary.Drugs.ATC.G.G04BX16;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>G04BX16</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tiopronin is a thiol-containing compound used primarily for the prevention of cystine stone formation in patients with severe homozygous cystinuria. It acts by forming a mixed disulfide with cystine, making it more soluble and thus preventing stone formation. Tiopronin is an FDA-approved medication and remains available for clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for a typical adult population (18-65 years, both sexes, without significant renal or hepatic impairment). Specific PK studies in humans are limited.</p><h4>References</h4><ol><li><p>Carlsson, MS, et al., &amp; Lindgren, S (1993). Pharmacokinetics of oral tiopronin. <i>European journal of clinical pharmacology</i> 45(1) 79–84. DOI:<a href=&quot;https://doi.org/10.1007/BF00315354&quot;>10.1007/BF00315354</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8405034/&quot;>https://pubmed.ncbi.nlm.nih.gov/8405034</a></p></li><li><p>Gillet, P, et al., &amp; Netter, P (1995). Pharmacokinetics of tiopronin after repeated oral administration in rheumatoid arthritis. <i>Fundamental &amp; clinical pharmacology</i> 9(2) 205–206. DOI:<a href=&quot;https://doi.org/10.1111/j.1472-8206.1995.tb00283.x&quot;>10.1111/j.1472-8206.1995.tb00283.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7628836/&quot;>https://pubmed.ncbi.nlm.nih.gov/7628836</a></p></li><li><p>Hercelin, B, et al., &amp; Netter, P (1992). The pharmacokinetics of tiopronin and its principal metabolite (2-mercaptopropionic acid) after oral administration to healthy volunteers. <i>European journal of clinical pharmacology</i> 43(1) 93–95. DOI:<a href=&quot;https://doi.org/10.1007/BF02280762&quot;>10.1007/BF02280762</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1505618/&quot;>https://pubmed.ncbi.nlm.nih.gov/1505618</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Tiopronin;
